Related Experiment Video

Updated: Jul 7, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Hepatitis C as a cause of chronic liver disease in northern Pakistan

I A Malik1, N Ahmad, M Luqman

  • 1Pathology Department, Army Medical College, Rawalpindi.

JPMA. the Journal of the Pakistan Medical Association
|March 1, 1992
PubMed

Insights

Hepatitis C virus (HCV) antibodies were detected in only 6 of 45 chronic liver disease patients in northern Pakistan. Hepatitis B virus (HBV) infection was more prevalent, suggesting HBV, not HCV, is a primary cause of chronic liver disease in the region.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Chronic liver disease presents a significant global health burden.
  • Hepatitis C virus (HCV) and Hepatitis B virus (HBV) are major etiological agents.
  • Understanding the prevalence of these viruses is crucial for public health strategies.

Purpose of the Study:

  • To determine the prevalence of anti-HCV antibodies in patients with histologically confirmed chronic liver disease in northern Pakistan.
  • To investigate the etiological role of HCV in comparison to HBV in this patient cohort.

Main Methods:

  • Blood samples from 45 patients with chronic liver disease (chronic hepatitis, cirrhosis, hepatocellular carcinoma) were tested for anti-HCV antibodies.
  • Patient history, including blood transfusion, was reviewed.
  • Prevalence of HBV infection was assessed in the study population.

Main Results:

  • Anti-HCV antibodies were detected in 6 out of 45 patients (13.33% overall).
  • Prevalence rates varied by disease: 16.67% in chronic hepatitis, 12.5% in cirrhosis, and 11.11% in hepatocellular carcinoma.
  • None of the anti-HCV positive patients had a history of blood transfusion.
  • A significantly higher prevalence of HBV infection was observed in the chronic liver disease patients.

Conclusions:

  • Hepatitis C virus infection is not a common cause of chronic liver disease in northern Pakistan.
  • Hepatitis B virus infection plays a more significant etiological role in chronic liver disease in this region.
  • Further research is needed to elucidate the specific factors contributing to chronic liver disease in the absence of common viral etiologies.

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...